Regulations of Regenerative Medicine Including Clinical Application of iPS Cells in Japan

Abstract

Clinical studies of regenerative medicine using induced pluripotent stem (iPS) cells have recently been performed, especially in Japan. To promote regenerative medicine research using iPS cells, the related laws have been enacted in Japan, leading to the use of other bioresources. Here, we overview the legislation of regenerative medicine. In parallel with this legislation, Kyoto University Hospital and the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, have rapidly established a bioresource stocking system for the purpose of clinical study and therapy using iPS cells. Kyoto University Hospital and CiRA are now preparing for the use of stocked iPS cells and other bioresources based on joint research contracts between Kyoto University and external institutions.

Authors and Affiliations

Tatsuaki Tsuruyama

Keywords

Related Articles

Human Umbilical Cord Blood Stem Cells Differentiate into Keratinocytes under In Vitro Conditions and Culturing Differentiated Cells on Bacterial Cellulose Film

Mesenchymal stem cells (MSC) are capable of self renewing and differentiating into other cell types. Human umbilical cord blood (HUCB) has been investigated as an alternative source to bone marrow. The aim of our examina...

Cancer Stem- Like Cells in Melanoma Progression, Resistance and Recurrence: Significance for Melanoma Treatment

Human malignant melanoma is a highly aggressive tumor which demonstrates heterogeneity and a propensity to drug resistance. Despite improved treatment options, patients with advanced malignant melanoma continue have a po...

Protective Role of Bone Marrow Derived Mesenchymal Stem Cells-Conditioned Medium in the Infarcted Myocardium: The Potential Role of Selected Cytokines

This study examines the protective effects of mesenchymal stem cell-conditioned (CM) medium on heart tissue after induced myocardial infarction (MI). New Zealand White Rabbits were divided: MI, mesenchymal stem cells (MS...

Gene Expression Analysis of Rat Adipose Tissue-Derived Stem Cells

The aim of this study was to isolate and characterize rat Adipose Derived Mesenchymal Stem Cells (AD-MSCs) in order to evaluate the stemness markers gene expression levels, together with the assessment of phenotypic expr...

Vascular Regenerative Surgery: Promised Land for Tissue Engineers?

Cardiovascular cell therapy is a promising new field for the development of treatments for cardiovascular diseases, which remain a major cause of mortality around the world. In this review, we highlight the options curre...

Download PDF file
  • EP ID EP198016
  • DOI 10.19070/2328-3548-1600029
  • Views 93
  • Downloads 0

How To Cite

Tatsuaki Tsuruyama (2016). Regulations of Regenerative Medicine Including Clinical Application of iPS Cells in Japan. International Journal of Stem Cell Research and Transplantation (IJST), 4(4), 179-181. https://europub.co.uk./articles/-A-198016